Journal of the Neurological Sciences
Volume 211, Issue 1 , Pages 29-35 , 15 July 2003

Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies

Received 8 August 2002 ,Revised 14 November 2002 ,Accepted 4 February 2003.

References 

  1. Duffy PE, Tennyson VM. Phase and electron microscopic observations of Lewy bodies and melanine granules in substantia nigra and locus ceruleus in Parkinson's disease. J. Neuropathol. Exp. Neurol. 1965;24:398–414
  2. Roy S, Wolman L. Ultrastructural observations in Parkinsonism. J. Pathol. 1969;99:39–44
  3. Kosaka K. Lewy bodies in cerebral cortex. Report of three cases. Acta Neuropathol. 1978;42:127–134
  4. Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol. 1988;75:345–353
  5. Leigh PN, Probst A, Dale GE, Power DP, Brion JP, Dodson A, et al.  New aspect of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol. 1989;79:61–72
  6. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. α-Synuclein in Lewy bodies. Nature. 1997;388:839–840
  7. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, et al.  Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 1998;152:879–884
  8. Marui W, Iseki E, Nakai T, Miura S, Kato M, Uéda K, et al.  Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J. Neurol. Sci. 2002;195:153–159
  9. Dale GE, Probst A, Luthert P, Martin J, Anderton BH, Leigh PN. Relationships between Lewy bodies and pale bodies in Parkinson's disease. Acta Neuropathol. 1992;83:525–529
  10. Wakabayashi K, Hayashi S, Kakita A, Yamada M, Toyoshima Y, Yoshimoto M, et al.  Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol. 1998;96:445–452
  11. Iseki E, Marui W, Akiyama H, et al.  Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using α-synuclein-immunohistochemistry. Neurosci. Lett. 2000;286:69–73
  12. Iseki E, Marui W, Kosaka K, Akiyama H, Uéda K, Iwatsubo T. Degenerative terminals of the perforant pathway are human α-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease. Neurosci. Lett. 1998;258:81–84
  13. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113–1124
  14. Iseki E, Marui W, Kosaka K, Kato M, Yamamoto T, Ueda K. Clinicopathological multiplity of dementia with Lewy bodies. Neuropathology. 1999;19:386–394
  15. Iseki E, Takayama N, Furukawa Y, Marui W, Nakai T, Miura S, et al.  Immunohistochemical study of synphilin-1 in brains of patients with dementia with Lewy bodies-synphilin-1 is non-specifically implicated in the formation of different neuronal cytoskeletal inclusions. Neurosci. Lett. 2002;326:211–215
  16. Arima K, Ueda K, Sunohara N, Hirai S, Izumiyama Y, Tonozuka-Uehara H. Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res. 1998;808:93–100
  17. Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neurophil threads. Acta Neuropathol. 1994;87:554–567
  18. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, et al.  Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 1989;477:90–99
  19. Probst A, Ulrich J, Heitz U. Senile dementia of Alzheimer type: astroglial reaction to extracellular neurofibrillary tangles in the hippocampus. Acta Neuropathol. 1982;57:75–79
  20. Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyreuther K, et al.  Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc. Natl. Acad. Sci. U. S. A. 1990;87:1561–1565
  21. Fischer-Colbrie R, Hagn C, Schober M. Chromogranins A, B, and C: widespread constituents of secretory vesicles. Ann. N.Y. Acad. Sci. 1987;493:120–134
  22. Wakabawashi K, Takashi H, Obata K, Ikuta F. Immunocytochemical localization of synaptic vesicle-specific protein in Lewy body-containing neurons in Parkinson's disease. Neurosci. Lett. 1992;138:237–240
  23. Arai H, Lee VM, Hill WD, Greenberg BD, Trojanowski JQ. Lewy bodies contain β-amyloid precursor proteins of Alzheimer's disease. Brain Res. 1992;585:386–390
  24. Yasuhara O, Kawamata T, Aimi Y, McGeer EG, McGeer PL. Expression of chromogranin A in lesions in the central nervous system from patients with neurological diseases. Neurosci. Lett. 1994;170:13–16
  25. Nishimura M, Tomimoto H, Suenaga T, Nakamura S, Namba Y, Ikeda K, et al.  Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains. Brain Res. 1994;634:339–344
  26. Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H. Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann. Neurol. 2000;47:521–523
  27. Clayton DF, George JM. Synucleins in synaptic plasticity and neurodegenerative disorders. J. Neurosci. Res. 1999;58:120–129
  28. Iseki E, Marui W, Sawada H, Uéda K, Kosaka K. Accumulation of human α-synuclein in different cytoskeletons in Lewy bodies in brains of dementia with Lewy bodies. Neurosci. Lett. 2000;290:41–44
  29. Sherriff FH, Bridges LR, Gentleman SM, Sivaloganathan S, Wilson S. Markers of axonal injury in post mortem human brain. Acta Neuropathol. 1994;88:433–439
  30. Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, Katayama Y. α-Synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation. Brain Res. 2001;888:287–296
  31. Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, et al.  Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 1998;153:1365–1370
  32. Marui W, Iseki E, Ueda K, Kosaka K. Occurrence of human α-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer's disease. J. Neurol. Sci. 2000;174:81–84
  33. Mori F, Hayashi S, Yamagishi S, Yoshimoto M, Yamagishi S, Takahashi H, et al.  Pick's disease: α- and β-synuclein-immunoreactive Pick bodies in the dentate gyrus. Acta Neuropathol. 2002;104:455–461

PII: S0022-510X(03)00037-6

doi: 10.1016/S0022-510X(03)00037-6

Journal of the Neurological Sciences
Volume 211, Issue 1 , Pages 29-35 , 15 July 2003